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Fig. S1. The ubiquitin (Ub)-proteasome system (UPS), the Ub fusion technique, the 
N-terminal processing of newly formed proteins, and specificity of Met-aminopeptidases. 
(A) The UPS. Conjugation of Ub to other proteins involves a preliminary 
ATP-dependent step in which the last residue of Ub (Gly76) is joined, via a thioester bond, 
to a Cys residue of the E1 (Ub-activating) enzyme. The “activated” Ub moiety is then 
conjugated to a Cys residue in one of Ub-conjugating (E2) enzymes, and from there, 
through an isopeptide bond, to a Lys residue of an ultimate acceptor, denoted as “protein”. 
E2s function as subunits of E2-E3 Ub ligase complexes that can produce substrate-linked 
poly-Ub chains. These chains have specific Ub-Ub topologies, depending on the identity of 
a specific Lys residue of Ub that forms an isopeptide bond with C-terminal Gly76 of the 
adjacent Ub moiety in a poly-Ub chain. Specific poly-Ub chains can confer a processive 
degradation of a substrate by the 26S proteasome, or other metabolic fates. One role of E3 
is the recognition of a substrate’s degradation signal (degron). An individual mammalian 
genome encodes more than 800 distinct E3 Ub ligases. See also the main text. 
(B) The Ub fusion technique. In eukaryotes, linear fusions of Ub to other proteins 
are cotranslationally cleaved by deubiquitylases (DUBs) at the last residue of Ub, making 
it possible to produce, in vivo, different residues at the N-termini of otherwise identical 
proteins (1, 2). 
(C) N-terminal processing of nascent eukaryotic proteins by Nα-terminal acetylases 
(Nt-acetylases) and Met-aminopeptidases (MetAPs) (3). “Ac” denotes the Nα-terminal 
acetyl moiety. M, Met. X and Z, single-letter abbreviations for any amino acid residue. 
Yellow ovals denote the rest of a protein.  
(D) Met-aminopeptidases (MetAPs) cotranslationally cleave off the N-terminal Met 
residue of a nascent protein if a residue at position 2 belongs to the set of indicated 
residues (4, 5). Gly and Pro at position 2 are depicted in a different color because these 
residues, in contrast to other (indicated) small residues, are very rarely Nt-acetylated after 
the removal of N-terminal Met (3). 
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Fig. S2. The mammalian Arg/N-degron pathway and isoforms of the mouse Ate1 
R-transferase. Amino acid residues are denoted by single-letter abbreviations. A yellow 
oval denotes the rest of a protein substrate. 
(A) The mammalian Arg/N-end rule pathway. It targets proteins for degradation 
through their specific unacetylated N-terminal (Nt) residues. “Primary”, “secondary”, and 
“tertiary” refer to mechanistically distinct classes of destabilizing Nt-residues. Ntan1 and 
Ntaq1 are N-terminal amidases (Nt-amidases) that convert, respectively, the tertiary 
destabilizing Nt-residues Asn and Gln to Asp and Glu. The Ate1 R-transferase 
(arginyltransferase or Arg-tRNA-protein transferase) conjugates Arg, a primary 
destabilizing residue, to N-terminal Asp, Glu and (oxidized) Cys. “Type 1” and “type 2” 
refer, respectively, to two sets of primary destabilizing N-terminal residues, basic (Arg, 
Lys, His) and bulky hydrophobic (Leu, Phe, Trp, Tyr, Ile, and also Met, if the latter is 
followed by a bulky hydrophobic residue (Ф)). These sets of N-terminal residues are 
recognized by two distinct substrate-binding sites of N-recognins, the pathway’s E3 
ubiquitin ligases Ubr1, Ubr2, Ubr4, and Ubr5. Also indicated is the ability of 
Arg/N-recognin E3s to recognize specific internal (non-N-terminal) degrons in proteins 
that lack Arg/N-degrons. See the main text for references and further details. Yet another 
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branch of this proteolytic system, denoted as the Arg/N-degronp62 pathway and discovered 
by Kwon and colleagues, involves p62/Sqstm1, a non-E3 Arg/N-recognin and a 
component of autophagy-lysosome pathways (see the main text and Fig. S4) ((6-15) and 
refs. therein). 
(B) The exons, including alternative exons (1A/1B and 7A/7B) of the mouse Ate1 
gene, which encodes alternative splicing-derived isoforms of R-transferase. The deduced 
lengths (in amino acid residues) of the encoded Ate1 exons are indicated on top.  
(D) Mouse R-transferase isoforms that are produced through alternative splicing of 
Ate1 pre-mRNA. The terminology of these isoforms (Ate11A7A, Ate11A7B, Ate11B7A, 
Ate11B7B, Ate11A7AB, Ate11B7AB) is based on the presence or absence of the alternative 
exons 1A/1B and 7A/7B. Ate11A7AB and Ate11B7AB are minor Ate1 isoforms that result 
from the retention of both variants of exon 7 (16, 17). 
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Fig. S3. C-degrons and C-degron pathways in human cells. This diagram is a simplified 
summary of the 2018 discovery, by the laboratories of Elledge and Yen, of a large set of 
C-degrons in human proteins (18-20). Amino acid residues are denoted by single-letter 
abbreviations. A yellow oval denotes a protein substrate upstream of its C-terminus. The 
indicated C-terminal (Ct) sequences and individual Ct-residues, referred to as C-degrons, 
are targeted, in conjunction with internal Lys residues of individual C-degron substrates, 
by a broad range of Ub ligases, largely but not solely of the CRL class (18-20). See the 
main text for a brief discussion of C-degron pathways and the term “C-degron” for 
denoting this class of degradation signals. 
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Fig. S4. Autophagy-mediated versus proteasome-mediated degradation of Arg/N-degron 
substrates. Amino acid residues are denoted by single-letter abbreviations. A yellow oval 
denotes the rest of a protein substrate. 
Kwon and colleagues discovered that p62/Sqstm1 (called p62 below), a component 
of the autophagy-lysosome system, is also a non-E3 Arg/N-recognin that binds to cytosolic 
proteins bearing Nt-Arg or specific hydrophobic Nt-residues. p62 mediates the capture of 
these proteins by autophagy and their subsequent destruction in lysosomes (6-15). Either a 
proteasome inhibitor or natural stresses can up-regulate the p62/autophagy branch of the 
Arg/N-degron pathway (6-15). BiP (one of Hsp70 chaperones), calreticulin (CRT, another 
ER chaperone), and protein disulfide isomerase (PDI) are among ER-resident proteins that 
bear Nt-arginylatable Nt-residues such as Nt-Asp or Nt-Glu. Upon stresses, including heat 
stress and unfolded protein response (UPR), a fraction of these ER proteins is transferred 
to the cytosol, followed by their Nt-arginylation. The resulting Nt-Arg-bearing proteins are 
captured either by the p62 Arg/N-recognin and/or by E3 Arg/N-recognins, and are 
destroyed, respectively, by the autophagy-lysosome system and/or by the 26S proteasome 
(Fig. S2A) (6-15). In sum, the Arg/N-degron pathway is a major functional link between 
UPS and autophagy. 
The affinity of p62 for Nt-Arg (Kd of ~44 nM) is at least 50-fold higher than that of 
Ubr1/Ubr2 (12). If so, how can intracellular Ubr1, Ubr2, Ubr4 and Ubr5 E3s (Fig. S2A) 
compete, in vivo, with the relatively abundant p62 for their binding to proteins bearing 
Nt-Arg? One possibility is that the affinity of p62 for Nt-Arg may be regulated in living 
cells. Both basic and aromatic Nt-residues of polypeptides that interact with p62 bind to its 
~50-residue zinc finger-like ZZ domain, which is sequelogous (21) to the ~80-residue 
UBR domain of Ubr1/Ubr2 (6). 
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Fig. S5. Organization and cis-trans targeting of eukaryotic N-degrons. Amino acid 
residues are denoted by single-letter abbreviations. A yellow oval denotes the rest of a 
protein substrate. 
(A) Determinants of a eukaryotic N-degron. d, a destabilizing Nt-residue. K, a 
“ubiquitylatable” internal Lys residue. See also the main text and refs. (17, 22, 23). 
(B and C) Cis versus trans polyubiquitylation of an oligomeric Arg/N-degron 
substrate that can result in the degradation of a subunit that becomes linked to a poly-Ub 
chain (24). 
(D) Trans-degradation, in which a specific subunit of an oligomeric protein is 
polyubiquitylated but is not degraded by the 26S proteasome, for example, because that 
subunit lacks an unstructured region that is required for the initiation of degradation. 
Instead, a subunit-selective degradation another, nonubiquitylated subunit takes place. This 
mode of degradation was discovered by Matouschek and colleagues for oligomeric 
substrates of the Ub-fusion-degradation (UFD) pathway (25, 26). It remains to be 
determined whether an analogous trans-degradation of an oligomeric Arg/N-degron 
substrate can also occur. 
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Fig. S6. Natural proapoptotic protein C-terminal (Ct) fragments that are experimentally 
confirmed substrates of the Arg/N-degron pathway, and some proapoptotic Ct-fragments 
that remain to be verified as such substrates. The list of either confirmed or putative 
Arg/N-degron substrates in this and other figures (Figs. S7 and S8) is but a subset of the 
known list of putative Arg/N-degron substrates, most of which remain to be experimentally 
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verified as such. The name of a protein on the left is preceded by the acronym of a species 
(Hs, Homo sapiens; Mm, Mus musculus). Amino acid residues are indicated by single-
letter abbreviations. Arrowheads and enlarged residues, in red, indicate P1’ residues of 
cleavage sites, i.e., the Nt-residues of Ct-fragments of the indicated cleaved full-length 
proteins. Primary, secondary and tertiary destabilizing N-terminal residues are denoted as 
Ndp, Nds and Ndt, respectively (17, 27). If a depicted cleavage site is the one recognized by 
a caspase (the exceptions, in the present list, are the calpain cleavage sites that yield 
Asp-BclXL and Arg-Bid), the site is underlined. The residue number on the left is of the 
first shown residue of uncleaved protein, numbered as in a full-length protein. The number 
on the right is of the last residue of a full-length protein. 
The first section of this figure describes 10 previously identified natural 
proapoptotic Ct-fragments, specifically Cys-Ripk1, Cys-Traf1, Asp-Brca1, Leu-Limk1, 
Tyr-Nedd9, Arg-Bid, Asp-BclXL, Arg-BimEL, Asp-Epha4, and Tyr-Met. They were found 
to be short-lived substrates of the Arg/N-end rule pathway (28). The figure’s second 
section describes six other previously identified proapoptotic Ct-fragments (all of them are 
produced by caspases) bearing destabilizing Nt-residues that can be recognized by the 
Arg/N-degron pathway. These fragments remain to be verified as Arg/N-degron substrates. 
Asn-PkCδ is the Ct-fragment of the protein kinase Cδ (PkCδ) that can be generated 
by (in particular) caspase-3. This fragment bears Nt-Asn and is proapoptotic, in contrast to 
the full-length PkCδ kinase (29-33). Lys-PkCθ is the Ct-fragment of the protein kinase Cθ 
(PkCθ). This fragment can be generated by (in particular) caspase-3, bears Nt-Lys, and is 
proapoptotic, in contrast to the full-length PkCθ kinase (34). Trp-Etk is the Ct-fragment of 
the Etk/Bmc tyrosine kinase, a member of the Btk/Tek family of kinases, at least some of 
which regulate apoptosis. The Trp-Etk fragment can be generated by (in particular) 
caspase-3, bears Nt-Trp, and is proapoptotic, in contrast to the full-length Etk kinase (35). 
Gln-Slk is the Ct-fragment of Slk, a Ste20-related protein kinase that plays a role in 
regulation of actin fibers. The Gln-Slk fragment can be generated by (in particular) 
caspase-3, bears Nt-Gln, and is proapoptotic. The concomitantly produced Nt-fragment of 
Slk is also proapoptotic (36). Ile-Hhp1 is the Ct-fragment of the hematopoietic progenitor 
kinase 1 (Hpk1), a Ste20-related protein kinase whose functions include stimulation of the 
stress-activated protein kinases SAPKs/JNKs and the NF-κB transcriptional regulon. The 
Ile-Hpk1 fragment can be generated by (in particular) caspase-3, bears Nt-Ile, and is 
proapoptotic, in contrast to the full-length Hk1 kinase (37). Ile-Mlh1 is the Ct-fragment of 
the mismatch repair Mhl1 protein that can be generated by (in particular) caspase-3, bears 
Nt-Ile, resides in the cytosol (unlike the full-length nuclear MLH1) and is proapoptotic, in 
contrast to full-length MLH1 (38). 
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Fig. S7. Calpain-generated C-terminal (Ct) fragments of mammalian proteins that are 
either identified or predicted substrates of the Arg/N-degron pathway. The entries whose 
numbers are colored in green are the experimentally identified substrates of the 
Arg/N-degron pathway (39). The entries whose numbers are colored in black are predicted 
Arg/N-degron substrates. Each entry cites a calpain-generated Ct-fragment of a protein and 
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the fragment’s Nt-residue (in red, using three-letter abbreviations for amino acids), 
followed by a brief description of uncleaved (full-length) precursor protein. A calpain 
cleavage site, denoted by an arrowhead, is shown using single-letter abbreviations for 
amino acids. An enlarged P1’ residue (in red) becomes N-terminal upon the cleavage. The 
indicated residue numbers are the number of the first shown residue of a full-length protein 
and the number of its last residue, respectively. All entries are mouse proteins, with the 
exception of #14 and #27, which are human proteins.  
#1. Glu-Bak is the proapoptotic Ct-fragment of the apoptotic regulator BAK. 
Glu-BAK is generated by calpain-1 in vitro and is apparently formed in vivo as well (40). 
#2. Arg-Bid. Bid is a 22 kDa member of the BCL-2 family of apoptosis regulators (41-43). 
Although full-length Bid is already a proapoptotic protein, its Ct-fragments, which can be 
naturally produced by activated caspases, calpains or granzyme B, can be even more active 
than intact Bid as proapoptotic protein fragments (44). The cleavage of Bid by calpains 
produces the 14 kDa Arg71-Bid fragment (44-47) that has been shown to be a short-lived 
substrate of the Arg/N-degron pathway (48). #3. Asp-BclXL. BclXL is a 26 kDa 
antiapoptotic regulatory protein (41, 49). Under conditions that include glucose and 
oxygen deprivation, BclXL can be cleaved by activated calpain-1, resulting in the 21 kDa 
Asp61-BclXL Ct-fragment. In contrast to full-length BclXL, Asp
61-BclXL has proapoptotic 
activity (50), and has been shown to be a short-lived substrate of the Arg/N-degron 
pathway (48). #4. Arg-c-Fos is the Ct-fragment of the c-Fos transcriptional regulator. c-Fos 
is targeted for conditional degradation through more than one degron, including the path 
that includes the cleavage by calpains (51). #5. Glu-IκBα is the Ct-fragment of the IκBα 
subunit of the NFκB-IκBα complex in which the NFκB transcriptional regulator is 
inhibited by IκBα. The IκBα subunit is targeted for degradation either through a 
conditional phosphodegron or through a specific calpain-mediated cleavage (52). 
#6. Arg-Igfbp2 is the calpain-generated Ct-fragment of the insulin-like growth factor 
binding protein-2 (53). #7. Asp-Capns1 is the Ct-fragment of the calpain regulatory subunit 
that is cleaved by activated calpains (54, 55). #8. Arg-Atp2b2 is the Ct-fragment of the 
transmembrane Atp2b2 plasma membrane Ca2+ pump (PMCA) that ejects Ca2+ from cells. 
This pump is activated either by the binding of Ca2+/calmodulin or by the calpain-mediated 
truncation of Atp2b2 that generates the Arg-Atp2b2 fragment and thereby activates the 
pump (56). #9. Leu-Capn1 is the auto-generated, catalytically active Ct-fragment of 
calpain-1 (57, 58). #10. Arg-Ankrd2. Ankrd2 (Marp2, Arpp), a member of the MARP 
(muscle ankyrin repeat protein) family, functions as a negative regulator of muscle 
differentiation (59). Calpains can produce the 30 kDa Arg103-Ankrd2 Ct-fragment (60). 
#11. Tyr-Grm1. Grm1 is the Ct-fragment of the mGluR1α transmembrane metabotropic 
glutamate receptor (61). Receptors containing the calpain-truncated mGluR1α Ct-fragment 
can elevate cytosolic Ca2+ but cannot activate PI3K-Akt signaling pathways, in contrast to 
uncleaved receptors (61, 62). #12. Lys-Ica512. Ica512 (Ptprn) is a member of the 
transmembrane receptor protein phosphatase family (63). The 43 kDa calpain-generated 
mouse Lys609-Ica512 Ct-fragment enters the nucleus and acts as a transcriptional regulator 
(63, 64). #13. Phe-GluN2a. GluN2a (NMDA-R2a) is a subunit of the N-methyl-D-
aspartate receptor (NMDAR), a glutamate receptor that can function as a ligand-gated Ca2+ 
channel (65, 66). The GluN2b subunit of NMDAR can also be cleaved by calpains (67). 
Ct-fragments of NR2A and NR2B contain domains required for the association of these 
subunits with other synaptic proteins. NMDAR receptors lacking a Ct-region of GluN2a 
could function as glutamate-gated Ca2+ channels but the intracellular traffic of cleaved 
receptors and their electrophysiological properties were altered (68). #14. Asn-DSCR1 
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(Rcan1) is the calpain-generated Ct-fragment of the Down syndrome critical region 1 
protein Dscr1, which binds to Raf1, inhibits the phosphatase activity of calcineurin, and 
enhances its degradation. The Asn-DSCR1 fragment does not bind to the Raf1 kinase (69). 
#15. Arg-Glyt1a is the Ct-fragment of the transmembrane Glyt1a glycine transporter (70). 
Another Gly transporter, Glyt1b, is also cleaved by calpains, yielding the Arg-Glyt1b 
fragment (70). These Ct fragments are still active as transporters but are impaired in their 
ability to remove Gly (an inhibitory neurotransmitter) from synaptic clefts (70). 
#16. Asn-Cav1.1 is the Ct fragment of the voltage-gated transmembrane Ca
2+ channel. This 
(apparently) calpain-generated fragment is noncovalently associated with the rest of the 
channel and can inhibit its activity. Upon dissociation from the channel, the Asn-Cav1.1 
fragment enters the nucleus and functions as a transcriptional regulator (71-74). 
#17. Lys-cortactin is the Ct-fragment of cortactin, a protein that regulates actin 
polymerization (75). #18. Asn-Bfl-1. Bfl-1 is antiapoptotic regulatory protein whose 
cleavage by calpain-1 generates the Asn72-Bfl-1 proapoptotic Ct-fragment (76). 
#19. Arg-dystrophin is the calpain-generated Ct-fragment of a major cytoskeletal protein in 
the skeletal muscle (77). #20. Gln-Ryr1 is the Ct-fragment of the Ryr1 ryanodine receptor, 
a Ca2+ channel in the ER (78) that mediates the efflux of Ca2+ from the ER into the cytosol. 
Calpain-mediated cleavage of Ryr1 increases Ca2+ efflux (79). #21. Arg-Mef2d is the 
Ct-fragment of the Mef2d myocyte enhancer factor 2d, a transcriptional regulator that 
contributes to neuronal survival, development, and synaptic plasticity (80). #22. Gln-talin 
is the calpain-generated Ct-fragment of talin, an adaptor protein that interacts with the 
integrin family of cell adhesion transmembrane proteins (56, 81, 82). #23. Arg-p39 is the 
calpain-generated Ct-fragment of the p39 activator of the Cdk5 protein kinase (83). The 
indicated cleavage site is located immediately downstream of two other closely spaced 
(and strongly conserved) calpain cleavage sites in p39. A cleavage at any one of these sites 
yields a predicted Arg/N-degron substrate. #24. Gln-Egfr is one of calpain-generated 
Ct-fragments of the transmembrane epidermal growth factor (EGF) receptor protein kinase 
(84). Remarkably, all 7 calpain cleavage sites in the cytosol-exposed domain of the 
170-kDa EGFR contain P1’ residues that are recognized as destabilizing by the 
Arg/N-degron pathway (84). #25. Leu-β-catenin is the calpain-generated Ct-fragment of 
β-catenin, a conditionally short-lived cytoskeletal protein and transcriptional regulator. The 
Leu-β-catenin fragment is a nuclear protein that activates specific genes in conjunction 
with other transcription factors (85). #26. Leu-NF2 is the calpain-generated Ct-fragment of 
NF2 (merlin), a tumor suppressor and cytoskeletal protein. Loss of function NF2 mutants 
result in autosomal-dominant neurofibromatosis, a predisposition to specific kinds of brain 
tumors (86). #27. Arg-caspase-9 is the Ct-fragment of caspase-9, which can be inactivated 
by calpains (87), followed by the (predicted) degradation of the Arg-caspase-9 Ct-fragment 
by the Arg/N-degron pathway. #28. Leu-troponin T2 is the Ct-fragment of the cardiac 
troponin T that is produced by calpain-1 in the troponin-containing cardiac myofibril 
complex (88). #29. Lys-PkCα is the calpain-generated Ct-fragment of PkCα, a broadly 
expressed Ser/Thr kinase of the PKC family (89). Being catalytically active but no longer 
controlled by the regulatory Nt-domain of the full-length PkCα, the Lys-PkCα fragment 
can be toxic, for example, upon its formation in an ischemic heart (90). #30. Leu-Rad21 is 
the calpain-generated Ct-fragment of the Scc1/Rad21 subunit of the chromosome-
associated cohesin complex (91). The calpain-mediated generation of Leu-Rad21 
contributes to the control  of chromosome cohesion/segregation, together with processes 
that include the separase-mediated cleavage of the same Rad21 subunit of cohesin (91-94). 
#31. Phe-PkCγ is the calpain-generated Ct-fragment of PkCγ, a Ser/Thr kinase of the PKC 
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family (89). The Phe-PkCγ fragment is constitutively active as a kinase, because it lacks 
the regulatory Nt-domain of the full-length PkCγ kinase (89). #32. Leu-STEP33 is the 
Ct-fragment of the striatal-enriched STEP61 phosphatase, a brain-specific Tyr-phosphatase 
whose substrates include the MAPK-family kinases Erk1/2 and p38. The calpain-generated 
Leu-STEP33 fragment lacks phosphatase activity (95). #33. Leu-Camk-IV is the calpain-
generated Ct-fragment of the Ca2+/calmodulin-dependent kinase-IV. This fragment lacks 
kinase activity (96). #34. Leu-vimentin is the calpain-generated Ct-fragment of vimentin, a 
component of intermediate filaments (97). 
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Fig. S8. Retention of destabilizing activity (but not necessarily of the identity) of P1’ 
residues in calpain cleavage sites during evolution of vertebrates. Arrowheads indicate 
calpain cleavage sites. P1’ residues, which become N-terminal upon the cleavage, are 
larger and colored. Domain organization and approximate location of a calpain cleavage 
site are indicated for each protein. The diagrams and indicated residue numbers are of 
mouse (Mus musculus (Mm)) proteins. (A) Bak. (B) Grm1. (C) IκBα. (D) GluN2a. 
(E) Ankrd2. (F) Capsn1. Note the retention, during evolution, of destabilizing activity (but 
not necessarily of the identity) of P1’ residues in these proteins. See also Fig. S7. 
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Fig. S9. Regulation of peptide import by the Arg/N-degron pathway in S. cerevisiae. 
(A) The “primed” cascade of Ubr1 phosphorylation in which the Yck1/Yck2-mediated 
phosphorylation on Ser300 of Ubr1 is essential for the normal regulation of peptide import 
(98). (B) Ubr1-mediated regulation of peptide import, and the involvement of the SPS 
pathway (99-103). Cup9 is a transcriptional repressor of the regulon that includes PTR2, 
which encodes the major importer of di/tripeptides. In the absence of Ubr1 (in ubr1 
cells), Cup9 becomes relatively long-lived, accumulates to higher levels, and extinguishes 
expression of Ptr2. Therefore ubr1 cells cannot import di/tripeptides. In wild-type 
(UBR1) cells growing in the absence of extracellular di/tripeptides, a low but non-zero 
number of Ubr1 molecules have their third substrate-binding site “open” (not 
autoinhibited) and therefore can target Cup9 for degradation (t1/2 ~ 5 min) via its internal 
degron, resulting in a weak but non-zero expression of the Ptr2 transporter. In wild-type 
(UBR1) cells growing in the presence of extracellular di/tripeptides (some of which bear 
type-1 and type-2 destabilizing Nt-residues), the imported di/tripeptides interact with the 
type-1 and type-2 binding sites of Ubr1. This binding allosterically increases the fraction 
of Ubr1 molecules whose third (Cup9-specific) site is “open” (active). The result is a 
decrease in the t1/2 ~ of Cup9 from ~5 min to 1 min or less, leading to negligible 
steady-state levels of Cup9, and consequently to a strong induction of the Ptr2 transporter 
(101-103). Also shown is the amino acid-sensing SPS pathway which can influence the 
import of peptides at least in part through the Yck1/Yck2-mediated phosphorylation of 
Ubr1 on Ser300. This phosphorylation is required (through a mechanism that remains to be 
understood) for normal levels of Ubr1 activity in the Ptr2-Cup9-Ubr1 circuit (98). 
  
  
16 
 
 
 
 
Fig. S10. Co-formation of C-degron and N-degron upon Usp1 autocleavage (18, 19, 28). 
(A) Sequence alignments, among vertebrates, of the catalytic domains of Usp1 and 
its autocleavage site, with amino acid residues numbered as in human Usp1. Key residues 
of the catalytic triad are in red, and are also marked by black circles. The Ub-like domain 
(Ubl, in green), with its last Gly-Gly 2-residue sequence (in green and a larger font size) 
abuts the autocleavage site of Usp1. The Gln (Q) P1’ residue of the autocleavage site is in 
red and a larger font size. This residue, #672 in human Usp1 and #670 in mouse Usp1, 
becomes N-terminal after the autocleavage of Usp1.  
(B) The enzymatic cascade that includes the autocleavage of Usp1 and the 
Arg/N-degron pathway, which destroys the Gln-Usp1Ct fragment (28). 
As described in the main text, the Usp1 deubiquitylase (DUB) forms a heterodimer 
with Uaf1, a non-DUB protein. Usp1 can autocleave immediately after its internal Gly-Gly 
sequence (104). Nevertheless, the DUB activity of autocleaved Usp1 can be transiently 
maintained, inasmuch as Usp1Nt, the Nt-fragment of autocleaved Usp1, can remain bound 
to the Gln-Usp1Ct Ct-fragment within the cleaved Usp1-Uaf1 heterodimer. The 
Ct-sequence Gly-Gly of the Usp1Nt Nt-fragment can act as a C-degron, which is 
recognized by the Kldch2 adaptor subunit of the Clr2 Ub ligase. In the resulting 
mechanism (not yet analyzed in detail), Uaf1 can hold together two Usp1 fragments, 
allowing them to function, temporarily, as a DUB enzyme, until successful attacks, on both 
fragments, by the N-degron and C-degron pathways. Usp1 is the first experimentally 
addressed setting in which an N-degron and a C-degron can be co-created upon a cleavage 
(self-cleavage, in this case) of a full-length protein((18, 19, 28, 104) and refs. therein).. 
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